Populace pharmacokinetic-pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in topics with early Alzheimer's disease.Disclaimer: The data supplied on this web page just isn't a substitute for Qualified medical suggestions, prognosis, or treatment method. If you have any thoughts or worries about you